HealthTech

Following Ant Group’s acquisition of Haodf, a healthcare platform specializing in online doctor consultations, Ant Group President Cyril Han and Haodf.com Founder Hang Wang have jointly announced their plans to drive AI-powered healthcare innovations.

Singapore-headquartered healthcare investor August Global Partners (AGP) is investing in Vietnam=based genomic testing company Gene Solutions (GS) through a proprietary funding round.

Tamarind Health, a Singapore-based pan-Asian oncology-focused group backed by investors including Temasek unit 65 Equity Partners, is offering S$0.456 ($0.34) per share to privatize cancer specialist TalkMed Group.

Malaysia-listed telecommunication firm CelcomDigi Berhad, through its Innovation Centre, have entered a strategic partnership with healthcare provider KPJ Healthcare Berhad (KPJ) to advance cross-border access to healthcare through telemedicine.

Entrepreneurs are often faced with a challenge: how to avoid having their ideas and business models quickly copied by established companies. I would like to share the example of Hims to explore this issue.

In a landmark for medical innovation, Vietnam’s Vinmec Times City International Hospital has carried out Southeast Asia’s first chest wall reconstruction using a 3D-printed titanium implant. The operation, aimed at saving the life of a 55-year-old woman with a large, aggressive chest tumor, not only highlights the potential of 3D printing in medicine but…

WhiteCoat Global, a Singapore-based digital healthcare provider, has announced it will be acquiring Good Doctor Indonesia, the telemedicine platform with the largest insurer and corporate client network in Indonesia.

Technology plays a pivotal role in addressing key social issues in Vietnam. In #Healthcare, tools like #Genetic decoding help doctors deliver personalized treatments and prioritize high-risk patients, while also aiding in nutrition and disease prevention. In #Education, digital platforms can bring quality learning to rural areas, leveling the playing field…

Generative AI has come a long way from its humble beginnings. With its ever-expanding capabilities, it promises a future where machines can aid human creativity and problem-solving in unprecedented ways. The potential applications of #GenAI in #ClinicalResearch and trials are particularly exciting, promising faster, more efficient, and more ethical…

Singapore-based private equity firm Mandala Capital has kicked off this year with a full exit from its investment in Edward Food Research and Analysis Centre (EFRAC), an Indian laboratory testing firm.